Beaufort Securities view of Collagen Solutions: Collagen Solutions made considerable progress in the fiscal year gone by following the acquisition of Southern Lights Ventures 2002 Limited, as the latter has
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, has told DirectorsTalk that it is
Collagen Solutions Plc CEO Stewart White discusses the release of it’s Final Results for Year End Mar 31 2015.
Panmure Gordon Analyst Dr Mike Mitchell said this morning on Collagen Solutions: “Prelim results have delivered a performance in-line with our expectations. The company reports revenue and other income of
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, has given DirectorsTalk its final results
Collagen Solutions’ Stewart White discusses the granting of a new patent in the US to Southern Lights Biomaterials in this exclusive interview with DirectorsTalk
Collagen Solutions’ Stewart White discusses the trading update, the NovaBone announcement and expectations of £100 million in this exclusive interview with DirectorsTalk
Collagen Solutions’ Stewart White discusses their Southern Lights Biomaterials acquisition and their outlook for 2015 in this exclusive interview with DirectorsTalk
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
